Skip to content

5401 S. Congress Ave, Ste 201 Atlantis, FL 33462

(561)995-6971

(561)569-8309

Pay Bills

Home
Meet The Team
Conditions We Treat
Services
Resources
Contact Us

Home
Meet The Team
Conditions We Treat
Services
Resources
Contact Us

Category: us

Search

Investigational Long COVID Therapy Enrolls First Phase 2 Participant

Carson City,-based NevBiovie announced today it has enrolled its first participant for it phase 2

May 15, 2025 No Comments

Peptide-Decorated Liposomes Enhance Drug Delivery Against Candida auris and Candida albicans

Candida auris cells Image credits: Unsplash Candida infections pose a clinical challenge due to the

May 15, 2025 No Comments

An Infection Prevention Method That We Forget?

Handwashing often takes place after encounters with people, using the bathroom, or touching doors or

May 15, 2025 No Comments

Addressing the Infectious Disease Challenges in Immunocompromised Patients

Joshua A Hill, MD, FIDSA, an infectious disease specialist at Fred Hutchinson Cancer Center and

May 15, 2025 No Comments

New Report Calls For Funding Treatments, Greater Emphasis on Chronic Lyme Disease

This deer tick, or blacklegged tick, Ixodes scapularis, as it was questing on a blade

May 14, 2025 No Comments

Safety and Immunogenicity Results for GS-2829 and GS-6779

A Phase 1a study in New Zealand evaluated the safety, tolerability, and immunogenicity of two

May 14, 2025 No Comments

Another Vaccine-Preventable Disease Seeing a Major Resurgence

Pertussis (whooping cough) is a bacterial infection caused by the bacterium Bordetella pertussis, and is

May 14, 2025 No Comments

Global Study Reports 98.9% SVR with SOF/VEL in Over 7,000 Hepatitis C Patients

A multinational real-world study of 7,027 patients treated with sofosbuvir/velpatasvir (SOF/VEL) for hepatitis C virus

May 14, 2025 No Comments

Greater Incidence of Antimicrobial Resistant Infections in Cancer Outpatients

Image credit: Ivan Samkov, Pexels Outpatients with cancer were found to be at a greater

May 13, 2025 No Comments

Colonoscopic Administration of Rebyota Shows Effectiveness for Preventing Recurrent C difficile Infection

A phase 3b clinical trial has demonstrated that fecal microbiota, live-jslm (RBL), delivered via colonoscopy

May 13, 2025 No Comments

Schedule an Appointment

Quick Links

Home
Meet The Team
Services
Resources
Contact Us

Patient Forms

Consent Form
Notice of Privacy Practices
Patient Info
Intake Form
Insurance Information

Contact Us

Monday - Friday : 09:00 AM - 04:30 PM
5401 S. Congress Ave, Ste 201 Atlantis, FL 33462

Copyright © 2024 atlasidp.

Privacy Policy
Terms & Condition

Home
Meet The Team
Conditions We Treat
Services
Resources
Contact Us